Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Current Assets (2022 - 2025)

Historic Current Assets for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $273.8 million.

  • Praxis Precision Medicines' Current Assets fell 2394.24% to $273.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.8 million, marking a year-over-year decrease of 2394.24%. This contributed to the annual value of $404.4 million for FY2024, which is 37640.43% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' Current Assets stood at $273.8 million, which was down 2394.24% from $306.6 million recorded in Q2 2025.
  • Praxis Precision Medicines' Current Assets' 5-year high stood at $404.4 million during Q4 2024, with a 5-year trough of $84.9 million in Q4 2023.
  • Moreover, its 4-year median value for Current Assets was $211.8 million (2024), whereas its average is $220.8 million.
  • Per our database at Business Quant, Praxis Precision Medicines' Current Assets tumbled by 5973.86% in 2023 and then soared by 37640.43% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Current Assets (Quarter) stood at $110.8 million in 2022, then decreased by 23.42% to $84.9 million in 2023, then soared by 376.4% to $404.4 million in 2024, then tumbled by 32.28% to $273.8 million in 2025.
  • Its last three reported values are $273.8 million in Q3 2025, $306.6 million for Q2 2025, and $333.6 million during Q1 2025.